You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance

€2.42

SKU: product-article-21170 Category: General

Description
Reviews (0)

Description

P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance

Reviews

There are no reviews yet.

Be the first to review “Article: P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance”

Top

Article: P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in melanoma

Article: Highlights in breast cancer

Article: Highlights in gynaecological cancers